p63 expression in odontogenic cysts.
暂无分享,去创建一个
F. Carinci | A. Santarelli | A. Piattelli | C. Rubini | R. Leonardi | R. Caltabiano | L. Lo Muzio | A. Fior | P. Bufo | L. Trevisiol | S. Lanzafame | T. Pieramici
[1] B. Li,et al. Expression of p16 and CDK4 in oral premalignant lesions and oral squamous cell carcinomas: a semi-quantitative immunohistochemical study. , 2007, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[2] C. Ligorio,et al. High DeltaN p63 isoform expression favours recurrences in odontogenic keratocyst--odontogenic keratocystic tumour. , 2006, International journal of oral and maxillofacial surgery.
[3] J. Bouchal,et al. Immunohistochemical analysis of the biological potential of odontogenic keratocysts. , 2006, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[4] S. Zhang,et al. Molecular evidence supporting the neoplastic nature of odontogenic keratocyst: a laser capture microdissection study of 15 cases , 2005, Histopathology.
[5] Y. Abiko,et al. Cell proliferation, apoptosis and apoptosis-related factors in odontogenic keratocysts and in dentigerous cysts. , 2005, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[6] A. Hirshberg,et al. The correlation between epithelial cell proliferation and inflammation in odontogenic keratocyst. , 2004, Oral oncology.
[7] H. Kumamoto,et al. PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts. , 2004, International journal of oral and maxillofacial surgery.
[8] G. Godoy,et al. Immunohistochemical assessment of extracellular matrix components in syndrome and non-syndrome odontogenic keratocysts. , 2004, Oral diseases.
[9] Narasimhan P. Agaram,et al. Molecular analysis to demonstrate that odontogenic keratocysts are neoplastic. , 2004, Archives of pathology & laboratory medicine.
[10] Y. K. Chen,et al. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas. , 2003, Clinical otolaryngology and allied sciences.
[11] Y. K. Chen,et al. Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal pouch squamous cell carcinogenesis. , 2003, Oral diseases.
[12] A. Piattelli,et al. Calretinin expression in odontogenic cysts. , 2003, Journal of endodontics.
[13] S. Douc-Rasy,et al. TP53 family members and human cancers , 2003, Human mutation.
[14] K. Kiuchi,et al. p63 expression in normal human epidermis and epidermal appendages and their tumors , 2003, Journal of cutaneous pathology.
[15] R. Mantovani,et al. Complex Transcriptional Effects of p63 Isoforms: Identification of Novel Activation and Repression Domains† , 2002, Molecular and Cellular Biology.
[16] R. Nenutil,et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells , 2002, The Journal of pathology.
[17] J. Reis-Filho,et al. p63 expression in normal skin and usual cutaneous carcinomas , 2002, Journal of cutaneous pathology.
[18] S. Riethdorf,et al. Human papillomaviruses, expression of p16, and early endocervical glandular neoplasia. , 2002, Human pathology.
[19] W. Kim,et al. Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. , 2002, Human pathology.
[20] C. Weghorst,et al. Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14ARF. , 2002, International journal of oncology.
[21] M. Shear. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 3. Immunocytochemistry of cytokeratin and other epithelial cell markers. , 2002, Oral oncology.
[22] M. Shear. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 2. Proliferation and genetic studies. , 2002, Oral oncology.
[23] M. Oren,et al. Physical Interaction with Human Tumor-derived p53 Mutants Inhibits p63 Activities* , 2002, The Journal of Biological Chemistry.
[24] M. Shear,et al. The aggressive nature of the odontogenic keratocyst: is it a benign cystic neoplasm? Part 1. Clinical and early experimental evidence of aggressive behaviour. , 2002, Oral oncology.
[25] E. Sturgis,et al. Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. , 2002, Human pathology.
[26] A. Piattelli,et al. Ki-67 expression in dentigerous cysts, unicystic ameloblastomas, and ameloblastomas arising from dental cysts. , 2002, Journal of endodontics.
[27] A. Yang,et al. On the shoulders of giants: p63, p73 and the rise of p53. , 2002, Trends in genetics : TIG.
[28] U. Moll,et al. p53, p63 and p73--solos, alliances and feuds among family members. , 2001, Biochimica et biophysica acta.
[29] A. Piattelli,et al. P53 protein expression in odontogenic cysts. , 2001, Journal of endodontics.
[30] H. Kumamoto,et al. Detection of cell cycle-related factors in ameloblastomas. , 2001, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[31] G. Blandino,et al. From p63 to p53 across p73 , 2001, FEBS letters.
[32] L. Barnes. Surgical Pathology of the Head and Neck , 2000 .
[33] J. Jen,et al. AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[34] F. Carey,et al. Expression of the p53 homologue p63alpha and deltaNp63alpha in normal and neoplastic cells. , 2000, Carcinogenesis.
[35] F. McKeon,et al. Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. , 1999, The Journal of investigative dermatology.
[36] Christopher P. Crum,et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.
[37] R. Ralhan,et al. pRb and p16 protein alterations in human oral tumorigenesis. , 1998, Oral oncology.
[38] A. Piattelli,et al. Differentiation of odontogenic keratocysts from other odontogenic cysts by the expression of bcl-2 immunoreactivity. , 1998, Oral oncology.
[39] A. Piattelli,et al. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. , 1998, Oral oncology.
[40] A. Yang,et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.
[41] T. Li,et al. Immunocytochemical expression of growth factors by odontogenic jaw cysts. , 1997, Molecular pathology : MP.
[42] J. Bartek,et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.
[43] T. Li,et al. p53 expression in odontogenic keratocyst epithelium. , 1996, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[44] P. Slootweg. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions. An immunohistochemical study. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[45] T. Li,et al. Epithelial cell proliferation in odontogenic keratocysts: a comparative immunocytochemical study of Ki67 in simple, recurrent and basal cell naevus syndrome (BCNS)-associated lesions. , 1995, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[46] R. DePinho,et al. Inhibition of ras-induced proliferation and cellular transformation by p16INK4 , 1995, Science.
[47] T. Li,et al. Quantification of PCNA+ cells within odontogenic jaw cyst epithelium. , 1994, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[48] P. Robinson,et al. Discrimination of parakeratinised odontogenic keratocysts from other odontogenic and non-odontogenic cyst types by expression of a 38kd cell-surface glycoprotein. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[49] D. Lane,et al. p53 protein in odontogenic cysts: increased expression in some odontogenic keratocysts. , 1992, Journal of clinical pathology.
[50] H. Philipsen. Keratocystic odontogenic tumour , 2005 .
[51] N. Hayward,et al. Expression and localization of mutant p16 proteins in melanocytic lesions from familial melanoma patients , 2004 .
[52] A. Iamaroon,et al. A comparative study of epithelial cell proliferation between the odontogenic keratocyst, orthokeratinized odontogenic cyst, dentigerous cyst, and ameloblastoma. , 2004, Oral diseases.
[53] R. Strocchi,et al. Expression of transforming growth factor-beta 1 (TGF-beta 1) in odontogenic cysts. , 2004, International endodontic journal.
[54] Y. Kwong,et al. Clinicopathological significance of p16 gene expression in the surgical treatment of head and neck squamous cell carcinomas , 2001 .